INNOVOTEX Appoints James Hussey as Vice Chairman of the Board to Accelerate Strategic Growth and Clinical Advancement
AUSTIN, TX, UNITED STATES, April 28, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a pre-clinical oncology therapeutics company advancing a novel class of oncology therapeutics based on Macrocycle Drug Conjugates (MDCs), today announced the …